
GulfBio · GB-TESAMORELIN-5MG
Tesamorelin 5mg
Taxes included. Shipping calculated at checkout.
Prices are set in USD. Local-currency amounts are indicative conversions for guidance only.
Shipped in discreet, unbranded packaging — no company name or product description on the outer box.
In stock
Quantity (0 in cart)
Description
Tesamorelin 5mg is a synthetic 44-amino acid GHRH analogue studied for its role in growth hormone stimulation and adipose tissue regulation.
Tesamorelin 5mg is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), consisting of a sequence of 44 amino acids. It is specifically modified by the addition of a trans-3-hexenoic acid group at the N-terminal position, which enhances its stability and resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4) compared to endogenous GHRH. In biochemical research, Tesamorelin is primarily investigated for its ability to stimulate the pituitary gland to synthesize and secrete endogenous growth hormone in a pulsatile manner. In vitro and in vivo studies have explored the impact of Tesamorelin on lipid metabolism and body composition, particularly its role in modulating adipose tissue distribution. Unlike synthetic growth hormone, Tesamorelin maintains the natural negative feedback loop involving insulin-like growth factor 1 (IGF-1), making it a significant subject of study for researchers examining metabolic regulation and growth hormone signaling pathways without the risks associated with exogenous GH administration.
Product Overview
Tesamorelin 5mg is a premium research peptide developed for laboratory evaluation. As a stabilized GHRH analogue, it offers researchers a highly consistent tool for studying the somatotropic axis and its influence on cellular metabolism. This product is intended strictly for scientific research and laboratory experimentation.
Specifications
Form: Lyophilized Powder Quantity: 5mg per vial Purity: >=99% (HPLC) Molecular Formula: C221H366N72O67S Storage: Store in a cool, dry place, away from direct light. For long-term stability, store at -20°C.
Research Applications
Current research involving Tesamorelin focuses on its potential to reduce visceral adipose tissue (VAT) and its effects on cardiovascular risk markers. Literature suggests that by increasing IGF-1 levels, it may influence metabolic profiles and glucose homeostasis. It is also a subject of interest in studies regarding cognitive function and neuroprotection due to the systemic effects of growth hormone secretagogues on brain health.
Certificate of Analysis
Review the batch documentation for identity and purity details.
COAs available upon request — contact GulfBio Support.
Research Use Notice
For laboratory research use only. Not for human or veterinary use.
Related items

Vials
Retatrutide 10mg
A potent triple-receptor agonist (GLP-1, GIP, and Glucagon) supplied as a 10mg lyophilised powder for metabolic research applications.

Vials
Retatrutide 15mg
A potent 15mg triple agonist peptide (GLP-1, GIP, and GCG) designed for advanced metabolic and endocrine research applications.

Vials
Retatrutide 20mg
A potent triple-hormone agonist (GLP-1/GIP/GCG) provided in a 20mg vial for advanced metabolic and biochemical research.
